NRAS mutation status is an independent prognostic factor in metastatic melanoma

Cancer, 04/27/2012

Patients with BRAF or NRAS mutations were more likely than WT patients to have central nervous system involvement at the time they were diagnosed with distant metastatic disease. NRAS mutation status was identified as an independent predictor of shorter survival after a diagnosis of stage IV melanoma.

Print Article Summary Cat 2 CME Report